XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Shares
Additional Paid in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Sep. 30, 2021 $ 7,488 $ 295,228,272 $ (284,122,092) $ (722) $ 11,112,946
Balance (in shares) at Sep. 30, 2021 7,486,120        
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   1,699,920     1,699,920
Options issued in settlement of accrued bonus   300,000     300,000
Net income (loss)     (4,721,766) 855 (4,720,911)
Balance at Dec. 31, 2021 $ 7,488 297,228,192 (288,843,858) 133 8,391,955
Balance (in shares) at Dec. 31, 2021 7,486,120        
Balance at Sep. 30, 2021 $ 7,488 295,228,272 (284,122,092) (722) 11,112,946
Balance (in shares) at Sep. 30, 2021 7,486,120        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)         (7,605,505)
Balance at Jun. 30, 2022 $ 8,984 298,624,137 (291,836,869) (1,554) 6,794,698
Balance (in shares) at Jun. 30, 2022 8,982,520        
Balance at Dec. 31, 2021 $ 7,488 297,228,192 (288,843,858) 133 8,391,955
Balance (in shares) at Dec. 31, 2021 7,486,120        
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   272,915     272,915
Deemed dividend - warrant repricing   110,105 (110,105)    
Common stock issued in public offering, net of offering costs $ 748 4,091,085     4,091,833
Common stock issued in public offering, net of offering costs (in shares) 748,200        
Fair value of warrants issued in connection with public offering   (3,350,400)     (3,350,400)
Net income (loss)     (1,758,685) (1,112) (1,759,797)
Balance at Mar. 31, 2022 $ 8,236 298,351,897 (290,712,648) (979) 7,646,506
Balance (in shares) at Mar. 31, 2022 8,234,320        
Increase (Decrease) in Stockholders' Equity          
Exercise of warrants $ 748 (674)     74
Exercise of warrants (in shares) 748,200        
Stock based compensation expense   272,914     272,914
Net income (loss)     (1,124,221) (575) (1,124,796)
Balance at Jun. 30, 2022 $ 8,984 298,624,137 (291,836,869) (1,554) 6,794,698
Balance (in shares) at Jun. 30, 2022 8,982,520        
Balance at Sep. 30, 2022 $ 12,909 305,399,008 (292,500,088) (2,890) $ 12,908,939
Balance (in shares) at Sep. 30, 2022 12,908,520       12,908,520
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   93,748     $ 93,748
Net income (loss)     (3,843,372) (874) (3,844,246)
Balance at Dec. 31, 2022 $ 12,909 305,492,756 (296,343,460) (3,764) 9,158,441
Balance (in shares) at Dec. 31, 2022 12,908,520        
Balance at Sep. 30, 2022 $ 12,909 305,399,008 (292,500,088) (2,890) $ 12,908,939
Balance (in shares) at Sep. 30, 2022 12,908,520       12,908,520
Increase (Decrease) in Stockholders' Equity          
Net income (loss)         $ (6,407,265)
Balance at Jun. 30, 2023 $ 12,909 306,091,402 (298,854,883) (55,360) $ 7,194,068
Balance (in shares) at Jun. 30, 2023 12,908,520       12,908,520
Balance at Dec. 31, 2022 $ 12,909 305,492,756 (296,343,460) (3,764) $ 9,158,441
Balance (in shares) at Dec. 31, 2022 12,908,520        
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   258,604     258,604
Net income (loss)     588,343 (37,167) 551,176
Balance at Mar. 31, 2023 $ 12,909 305,751,360 (295,755,117) (40,931) 9,968,221
Balance (in shares) at Mar. 31, 2023 12,908,520        
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   340,042     340,042
Net income (loss)     (3,099,766) (14,429) (3,114,195)
Balance at Jun. 30, 2023 $ 12,909 $ 306,091,402 $ (298,854,883) $ (55,360) $ 7,194,068
Balance (in shares) at Jun. 30, 2023 12,908,520       12,908,520